Untitled design (6)
search
WHO 1
Bio Farma Achieves 100% in 2026 WHO Accreditation Assessment, Affirming Measles and Rubella Laboratory Competence Tuesday, 15 September 2026
Bio Farma
Bio Farma Wins Indonesia Most Reputable Companies Award 2026, Reinforcing Reputation Built on Capability and Trust Friday, 11 September 2026
Bio Rotavirus
Bio-RV, a Neonatal Rotavirus Vaccine Developed Through Bio Farma–MCRI Collaboration, Receives Marketing Authorization from the Indonesian Food and Drug Authority, BPOM Thursday, 3 September 2026
DSC09771
Bio Farma Receives Official Visit from the Governor of Victoria to Strengthen Strategic Cooperation in Health and Biotechnology Tuesday, 9 December 2025
DCVMN
26th DCVMN AGM Successfully Held: Bio Farma and DCVMN Strengthen Global Collaboration to Build a Resilient and Inclusive Vaccine Ecosystem Wednesday, 5 November 2025
WhatsApp Image 2025-10-30 at 13.39.28
Strengthening Global Collaboration to Build a Resilient and Sustainable Vaccine Ecosystem Thursday, 30 October 2025
WhatsApp Image 2025-10-27 at 10.09.53
Reinforcing Global Commitment to Health Resilience, Ahead of the 26th DCVMN Annual General Meeting in Bali Monday, 27 October 2025
WhatsApp Image 2025-10-25 at 07.33.47
Contributes to Shaping Global Health Standards: Bio Farma and DCVMN Strengthens International Vaccine Collaboration Saturday, 25 October 2025
Gedung Bio Farma (1) (1)
Indonesia’s Legacy in the Global Vaccine Landscape, Bio Farma and DCVMN Strengthen Health Resilience Through Global Partnership Wednesday, 22 October 2025
WhatsApp Image 2025-10-20 at 10.26.01
Indonesia Hosts the 26th DCVMN Annual General Meeting 2025, Bio Farma and DCVMN Strengthen Global Collaboration for Health Resilience Monday, 20 October 2025
Gedung Bio Farma (1) (1)
Announcement of Changes in the Board of Managementof PT Bio Farma (Persero)  Monday, 8 September 2025
WhatsApp Image 2025-01-30 at 09.27.55
Bio Farma Signs Collaboration Agreement with Serum Institute of India Wednesday, 5 February 2025

Change Language

EN